Article (Scientific journals)
Inhibiteur des SGLT2 ou analogue du GLP-1 chez un patient diabetique avec maladie cardiovasculaire ?
Scheen, André; Paquot, Nicolas
2018In Revue Médicale Suisse, 14 (615), p. 1460-1465
Peer Reviewed verified by ORBi
 

Files


Full Text
2018 RMS Inhibiteur des SGLT2 RMS_615_1460.pdf
Publisher postprint (4.41 MB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Abstract :
[en] Sodium-glucose cotransporter type 2 inhibitors (SGLT2is), with empagliflozin in EMPA-REG OUTCOME, and glucagon-like peptide-1 receptor agonists (GLP-1RAs), with liraglutide in LEADER, have proven their ability to reduce major cardiovascular events and mortality in patients with type 2 diabetes and established cardiovascular disease. Thus clinicians have to choose between the two options in patients at high risk. The choice should be based upon a personalized approach, which has to take into account the drug properties, especially the tolerance profile, and patient's individual characteristics. In patients with heart failure, the added value of a SGLT2i appears obvious while in those with advanced renal insufficiency, current evidence favours the use of a GLP-1RA.
Disciplines :
Pharmacy, pharmacology & toxicology
Endocrinology, metabolism & nutrition
Cardiovascular & respiratory systems
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Département des sciences cliniques
Paquot, Nicolas ;  Université de Liège - ULiège > Département des sciences de la santé publique > Diabétologie, nutrition et maladies métaboliques
Language :
French
Title :
Inhibiteur des SGLT2 ou analogue du GLP-1 chez un patient diabetique avec maladie cardiovasculaire ?
Alternative titles :
[en] SGLT2 inhibitor or GLP-1 receptor agonist in a type 2 diabetic patient with cardiovascular disease ?
Publication date :
2018
Journal title :
Revue Médicale Suisse
ISSN :
1660-9379
Publisher :
Medecine et Hygiène, Switzerland
Volume :
14
Issue :
615
Pages :
1460-1465
Peer reviewed :
Peer Reviewed verified by ORBi
Available on ORBi :
since 04 December 2018

Statistics


Number of views
273 (4 by ULiège)
Number of downloads
490 (3 by ULiège)

Scopus citations®
 
5
Scopus citations®
without self-citations
0

Bibliography


Similar publications



Contact ORBi